- Report
- February 2025
- 200 Pages
Global
From €4256EUR$4,490USD£3,555GBP
- Report
- March 2025
- 200 Pages
Global
From €4256EUR$4,490USD£3,555GBP
- Report
- March 2024
- 159 Pages
Global
From €7535EUR$7,950USD£6,295GBP
- Report
- February 2022
- 220 Pages
Global
From €9004EUR$9,500USD£7,522GBP
- Drug Pipelines
- April 2024
- 50 Pages
Global
From €1422EUR$1,500USD£1,188GBP
- Report
- April 2025
- 50 Pages
Global
From €2512EUR$2,650USD£2,098GBP
Isosorbide Dinitrate is a cardiovascular drug used to treat angina, a condition caused by reduced blood flow to the heart. It works by relaxing and widening blood vessels, allowing more blood to flow to the heart. Isosorbide Dinitrate is available in various forms, including tablets, capsules, and oral solutions. It is also available as a topical ointment for the treatment of anal fissures. Isosorbide Dinitrate is often used in combination with other drugs, such as nitroglycerin, to provide more effective relief from angina.
The Isosorbide Dinitrate market is highly competitive, with many companies offering generic and branded versions of the drug. Some of the major players in the market include Mylan, Teva Pharmaceuticals, Sandoz, and Sun Pharmaceuticals. Show Less Read more